Inspiratory Muscle Training in Individuals With Cystic Fibrosis

April 14, 2020 updated by: Patri-cia Angelica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte

Effects of Inspiratory Muscle Training in Individuals Who Have Cystic Fibrosis

Cystic fibrosis is a genetic disease that affects some organs of the human body. Among them, the lungs tend to be the most affected due to the accumulation of mucus in the airways, which in addition to avoiding the passage of air, favors pulmonary infections. With the evolution of the condition, secondary complications arise, such as postural changes, decreased respiratory muscle strength, decreased functional capacity and, consequently, quality of life. Therefore, respiratory muscle training may be an intervention that improves the respiratory condition of these individuals, allowing an improvement in the quality of life and may delay the evolution of respiratory symptoms. Thus, this study aims to investigate a home protocol of respiratory muscle training on respiratory muscle strength, lung function, quality of life, posture and functional capacity in adolescents and adults with cystic fibrosis. The researchers believe that the training can cause an improvement in the studied variables, and can be inserted in the usual treatment of these patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Norte
      • Natal, Rio Grande Do Norte, Brazil
        • Universidade Federal do Rio Grande do Norte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 25 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of cystic fibrosis, confirmed by the sweat test;
  • 14 - 25 years;
  • Clinical stability;
  • Absence of bacterial colonization for 4 weeks;
  • Both sexes;

Exclusion Criteria:

  • Inability to perform the protocol established by the study;
  • Present any intercurrence during data collection;
  • Being unable to understand and / or perform procedures.
  • Colonization during study participation;
  • Patient hospitalization due to worsening of the clinical picture.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: GExp
This group will perform the inspiratory muscle training with moderate load
This group will initiate inspiratory muscle training with 40% of the MIP load and each week will have a load increase of 10% of the initial MIP up to 4 weeks of training
ACTIVE_COMPARATOR: GCon
This group will initiate inspiratory muscle training with low load
This group will initiate inspiratory muscle training with 40% of the MIP load and each week will have a load increase of 10% of the initial MIP up to 4 weeks of training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Posture at 4 weeks
Time Frame: Baseline and after 4 weeks of training
Inclinometer Danoplus®
Baseline and after 4 weeks of training
Change from baseline Health-related quality of life at 4 weeks
Time Frame: Baseline and after 4 weeks of training
Health-related quality of life questionnaire (HRQoL)
Baseline and after 4 weeks of training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Respiratory muscle strength at 4 weeks
Time Frame: Baseline and after 4 weeks of training
MVD300®
Baseline and after 4 weeks of training
Change from baseline Pulmonary function at 4 weeks
Time Frame: Baseline and after 4 weeks of training
Spirometry test using Koko® device
Baseline and after 4 weeks of training
Change from baseline Functional capacity at 4 weeks
Time Frame: Baseline and after 4 weeks of training
three-minute step test
Baseline and after 4 weeks of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Victor Oliveira, Master, Universidade Federal do Rio Grande do Norte

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 5, 2019

Primary Completion (ACTUAL)

October 18, 2019

Study Completion (ACTUAL)

January 31, 2020

Study Registration Dates

First Submitted

November 6, 2018

First Submitted That Met QC Criteria

November 7, 2018

First Posted (ACTUAL)

November 9, 2018

Study Record Updates

Last Update Posted (ACTUAL)

April 16, 2020

Last Update Submitted That Met QC Criteria

April 14, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cystic Fibrosis

Clinical Trials on Inspiratory muscle training

3
Subscribe